PolyPeptide Group AG (SWX:PPGN)
Switzerland · Delayed Price · Currency is CHF 43.90
+0.10 (0.23%)
Aug 3, 2026, 2:45 PM CET
PolyPeptide Group AG Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, PolyPeptide Group AG stock has a consensus rating of "Buy" and an average price target of CHF 38.95. The average 1-year stock price forecast is 11.28% lower than the current stock price, while the lowest is CHF 25.80 (-41.23%) and the highest is CHF 45.44 (+3.51%).
Price Target: CHF 38.95 (-11.28%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for PolyPeptide Group AG stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Downgrades CHF 44.00 | Hold | Downgrades | CHF 44.00 | +0.23% | Jul 7, 2026 |
| Berenberg Bank | Berenberg Bank | Buy Maintains CHF 35.00 → CHF 38.00 | Buy | Maintains | CHF 35.00 → CHF 38.00 | -13.44% | Jun 16, 2026 |
| Barclays | Barclays | Buy Maintains CHF 33.00 → CHF 40.00 | Buy | Maintains | CHF 33.00 → CHF 40.00 | -8.88% | Jun 16, 2026 |
| UBS | UBS | Buy Maintains CHF 40.00 | Buy | Maintains | CHF 40.00 | -8.88% | May 7, 2026 |
Financial Forecast
Revenue This Year
491.89M
from 389.33M
Increased by 26.34%
Revenue Next Year
567.87M
from 491.89M
Increased by 15.45%
EPS This Year
0.87
from -0.64
EPS Next Year
1.55
from 0.87
Increased by 77.32%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.